Mechanism of Decrease in Transferrin Receptor Synthesis by Interferon-α Treated Human Lymphoblastoid Cells

K Muta1, J Nishimura1, Y Abe1

  • 1a Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan.

Leukemia & Lymphoma
|July 27, 2016
PubMed

Insights

Interferon-alfa (IFN-α) reduces transferrin receptor biosynthesis in Daudi cells, an iron-independent process. This may contribute to IFN-α's antiproliferative effects in hematological malignancies.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Hematological malignancies involve uncontrolled cell proliferation.
  • Interferon-alfa (IFN-α) exhibits antiproliferative effects in these cancers.
  • The precise mechanism of IFN-α's action requires further elucidation.

Purpose of the Study:

  • To investigate the effect of IFN-α on the transferrin receptor system in Daudi cells.
  • To determine the role of iron metabolism in IFN-α-induced antiproliferation.

Main Methods:

  • Daudi cells were treated with IFN-α (10(4)U/ml).
  • Surface transferrin receptor levels were quantified.
  • Transferrin receptor biosynthesis was assessed using (35)S-methionine labeling.
  • Iron uptake and ferritin content were measured.

Main Results:

  • IFN-α treatment decreased surface transferrin receptors by 40%.
  • This reduction was independent of iron chelation.
  • IFN-α significantly inhibited transferrin receptor biosynthesis.
  • Iron uptake and ferritin levels were reduced by 50%.

Conclusions:

  • IFN-α inhibits transferrin receptor biosynthesis in an iron-independent manner.
  • The resulting cellular iron deficiency may mediate the antiproliferative action of IFN-α.
  • These findings offer insights into IFN-α's therapeutic mechanism in hematological cancers.